Page last updated: 2024-08-17

quinoxalines and 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)piperidine

quinoxalines has been researched along with 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)piperidine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Konitsiotis, S; Maranis, S; Stamatis, D; Tsironis, C1

Other Studies

1 other study(ies) available for quinoxalines and 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)piperidine

ArticleYear
Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia.
    European journal of pharmacology, 2012, May-15, Volume: 683, Issue:1-3

    Topics: Animals; Anti-Dyskinesia Agents; Disease Models, Animal; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Infusions, Intraventricular; Levodopa; Male; Oxidopamine; Phenols; Piperidines; Putamen; Quinoxalines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, AMPA; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Substantia Nigra; Subthalamic Nucleus; Thiazoles

2012